Procalcitonin (PCT) is increasingly recognised as an important diagnostic parameter in clinical evaluation of the critically ill. This prospective study was designed to investigate PCT as a diagnostic marker of infection in critically ill patients with sepsis.
As emphasised by the American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference 1 definitions, clinical findings are valuable tools in diagnosing sepsis. The inflammatory response, whether caused by infection or a noninfectious insult shares common manifestations in ICU patients. Bacteriological findings may not be available concurrently with clinical signs, and a negative culture does not always exclude the presence of infection. Effective antimicrobial therapy should be initiated at the earliest possible time in the critically ill; however, it is usually difficult to distinguish patients with systemic infection from those who appear septic without any evidence of infection. White blood cell count and serum C-reactive protein (CRP) concentration are currently the most widely used parameters to support the infectious origin of the inflammatory response, however definite association of these parameters in discriminating infection as the cause of the inflammatory response has not been documented [2] [3] [4] .
In recent years, procalcitonin (PCT) has drawn attention as a possible marker of the systemic inflammatory response to infection. Although the exact site of PCT production in sepsis is still unclear, its association with the presence and the severity of infection has been demonstrated in critically ill patients 3, [5] [6] [7] [8] [9] [10] .
This prospective study was designed to analyse the relationship between sepsis severity and PCT levels in comparison with CRP concentration.
MATERIALS AND METHODS

Study Design
This study was performed in 75 infected patients and in 10 patients with systemic inflammatory response syndrome (SIRS). The Institutional Ethics Committee approved the study protocol and the patients or their proxies gave informed consent to participate. On the day of admission to ICU, patients were assigned to one of four clinical situations as SIRS, sepsis, severe sepsis and septic shock, according to the definitions of American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference 1 . Data was obtained between the day of admission and the day of discharge or death. Data collection was also terminated if the patient's initial diagnosis progressed or recessed to any other disease state. For example, patients with SIRS were assessed daily for any definable source of infection, and those in whom a site of infection was documented were then removed from further analysis.
All the patients were assessed daily for the presence of infection. Urine culture, microbiological surveillance of drainage systems and culture of removed catheters were systematically performed. Two blood cultures were performed on the admission day (during the first 24 hours), and afterwards if a patient's temperature was higher than 38°C. Respiratory tract infection was assessed according to chest X-ray and the presence of purulent tracheal secretions containing microorganisms. Patients were considered to have pneumonia when they met the clinical criteria and if the endotracheal aspirate culture yielded more than 10 5 colony-forming units. Ultrasound and CT scan examinations were performed when intra-abdominal infection was suspected. Lumbar puncture was performed when clinically indicated.
Identification of infection and assignment of the patients to the SIRS, sepsis, severe sepsis and septic shock groups was based on history, clinical presentation, X-rays, CT scans and microbiological tests. The decision regarding patients' inclusion in one of the sepsis groups and the prescription of antimicrobial therapy was accomplished by the agreement of five ICU physicians. If the physicians did not reach an agreement on the diagnosis of infection, those patients were not included in the study. The results of laboratory were not available during the study period.
Definitions
SIRS was characterized by the presence of at least two of the following criteria: 1) fever or hypothermia (temperature of >38°C or <36°C); 2) heart rate of >90 beats/min; 3) respiratory rate>20/min or P a CO 2 <32 mmHg; 4) white blood cell count >12000/mm 3 or <4000/mm 3 or the presence of >10% band forms. Sepsis was defined as SIRS with a documented infection. Severe sepsis was defined as the presence of sepsis and at least one of the manifestations of inadequate organ perfusion or sepsis-induced hypotension: 1) metabolic acidosis (pH <7.30); 2) hypoxaemia (P a O 2 /FiO 2 ratio <200); 3) oliguria (urine output <30 ml/h); 4) lactic acidosis (serum lactate level >2 mmol/l); 5) acute alteration of mental status. Septic shock was defined by the presence of sepsis accompanied by a sustained decrease in systolic blood pressure (<90 mmHg or a reduction by 40 mmHg or more from baseline) despite fluid resuscitation in the absence of other causes for hypotension (e.g., cardiogenic shock).
Exclusion Criteria
Patients older than 75 years of age or younger than 15 years of age were not enrolled in the study. Endstage cancer, chronic organ insufficiency, pregnancy and massive transfusion were the other exclusion criteria of the study.
Measurements
Data were collected including CRP and PCT on each ICU day, concurrently with Sequential Organ Failure Assessment (SOFA) and Acute Physiology and Chronic Health Evaluation II (APACHE II) scores. Blood samples were obtained from an arterial catheter every morning. CRP was measured by nephelometric assay (BN II, Dade-Behring, Marburg, Germany). Upper normal limit of CRP is 0.5 mg/dl. PCT was determined with an immunoluminometric assay allowing quantitative measurement of a wide range of PCT concentrations (B.R.A.H.M.S. Diagnostica GmbH, Berlin, Germany). Upper normal limit of PCT is 0.5 ng/ml. A physician who was blinded to the patients' clinical course performed PCT and CRP measurements.
Statistical Analysis
Kruskal Wallis ANOVA was used to compare data between four stages of disease. Mann Whitney-U test was used to compare independent samples. The initial PCT and CRP values were used to calculate the sensitivity and specificity, positive and negative predictive value for infection. The ability of PCT to predict infection (SIRS versus sepsis/severe sepsis/ septic shock) was evaluated using receiver operating characteristics (ROC) curves and the respective areas under the curve (AUC). The best cut-off values for the diagnosis of infection and for discrimination of disease states were determined with the Youden's index method. A P value below 0.05 was considered significant. Data analyses and statistics were performed using SPSS for Windows 10.0.1.
RESULTS
Eighty-five patients were studied. At the time of admission, all patients had a clinically suspected infection and fulfilled at least two criteria of SIRS. Ten patients who had no definable source of infection on admission day were enrolled in the SIRS group. Seventy-five infected patients were classified as sepsis (n=16), severe sepsis (n=18) and septic shock (n=41). SIRS, sepsis, severe sepsis and septic shock patients were similar regarding age (P=0.09) and gender (P=0.8). Demographic data, admission diagnosis and causative organisms of the infections are presented in Table 1 .
Data collection was terminated in five patients (50%) in SIRS, six patients (37.5%) in sepsis, seven patients (39%) in severe sepsis and 27 patients (66%) in septic shock due to resolution of the disease, death or progression or recession to any other disease state. Data collection was performed for 5.5±2.4 days (3-10, range) in SIRS, 6.5±3.5 days (2-13, range) in sepsis, 8.6±3.2 days (3-15, range) in severe sepsis and 3.8±1.6 days (2-7, range) in septic shock. Duration of data collection period was significantly shorter in septic shock than SIRS (P<0.05), sepsis (P<0.01) and severe sepsis (P<0.001).
Data was collected for a total of 469 days in 85 patients. PCT and CRP levels and APACHE II and SOFA scores were evaluated for 55 days in SIRS, 104 days in sepsis and 155 days in both severe sepsis and septic shock groups. The admission diagnoses of SIRS patients were chronic obstructive lung disease (n=3), postoperative respiratory insufficiency (n=2), myasthenia gravis (n=1), head trauma (n=2), myocardial infarction (n=1) and HELLP syndrome (n=1). Patients with SIRS demonstrated PCT levels of 0.73±1.37 ng/ml, which was significantly lower than the values obtained from patients with severe sepsis and septic shock (P<0.05 for both groups). PCT, CRP, SOFA and APACHE II scores did not differ significantly between patients with SIRS and sepsis.
Mean values of the daily PCT and CRP levels, SOFA and APACHE II scores in each clinical situation are presented in Table 2 . Parallel to SOFA and APACHE II scores, there was a consistent rise in PCT levels with increasing sepsis severity. The only significant difference in CRP levels was found between severe sepsis and septic shock patients (P<0.05)
Comparison of SIRS (n=10) and infected (n=75) patients demonstrated statistically significant differences in PCT levels (0.73±1.37 ng/ml vs 21 PCT levels demonstrated a higher sensitivity and specificity than CRP in identifying infection (Table 3) . At a cut-off level set at 1.31 ng/ml, PCT had a sensitivity of 73% and specificity of 83% to differentiate patients with SIRS from those with sepsis, severe sepsis and septic shock. PCT yielded the highest discriminative value in diagnosing infection with an AUC of 0.87 (Figure 1) .
The cut-off values of PCT to discriminate patients with SIRS from those with sepsis, patients with sepsis from those with severe sepsis and patients with severe sepsis from those with septic shock were found as 1.09, 5.56 and 26.63 ng/ml respectively. Relative frequencies of the PCT measurements in different disease stages are shown in Table 4 . Figure 2 demonstrates the different trends of initial and final PCT measurements of survivors (upper panel) and non-survivors (lower panel), indicating PCT levels remained elevated in non-survivors, whereas returning to normal levels in survivors.
DISCUSSION
This study confirmed the reliability of PCT as a marker of infection. We found that a cut-off level of 1.31 ng/ml could distinguish critically ill patients with infection from those with SIRS with a sensitivity of 73% and a specificity of 83%.
There are several studies in the literature evaluating the sensitivity and specificity of PCT in identifying infection in patients with different underlying pathologies 5, 7, 11 . In one of the pioneer studies, Assicot et al 5 demonstrated low PCT levels in those with no infection and very high levels in those with severe infection. De Werra et al 7 reported that medical ICU patients having PCT values above 1.5 ng/ml were most likely to have septic shock with a sensitivity of 100% and a specificity of 72%. Rau et al 11 evaluated patients with pancreatitis and found a cut-off level of 1.8 ng/ml predicting infectious complication with a diagnostic accuracy of 87%. On the other hand, cut-off value of bacterial infection was reported as 0.5 ng/ml in those patients with underlying active lupus erythematosis with a sensitivity of 100% and a specificity of 84% 12 . These findings suggested that the levels of PCT in differentiating infection might depend on the studied patient population.
Ugarthe et al 2 compared the usefulness of PCT and CRP in diagnosing infection in surgical and medical ICU patients, and found the best cut-off value as 0.6 ng/ml for PCT. PCT levels showed a slightly lower sensitivity and specificity than CRP values (67.6% and 61.3% for PCT, 71.8% and 66.6% for CRP respectively). Their results showed better infection discrimination with the combination of both parameters. Suprin et al 13 were not valuable indicators for distinguishing septic patients from the SIRS group without infection. In contrast to those studies, our data demonstrated that PCT is a more reliable marker than CRP for discriminating SIRS from infection. Higher sensitivity and specificity of PCT in diagnosing infection showed a greater area under the ROC curve for PCT (0.87) compared to CRP (0.41). Harbarth et al 14 have also shown that a cut-off level of 1.1 ng/ml could distinguish patients with SIRS from those with sepsis, severe sepsis and septic shock with a sensitivity of 97% and a specificity of 78%. In that study, PCT yielded the highest discriminative value with an area under the curve of 0.92. Recently Müller et al 8 investigated 101 medical ICU patients and found that PCT concentrations of >1 ng/ml had sensitivity of 89% and specificity of 94% for the diagnosis of sepsis.
The authors concluded that PCT levels are a more reliable marker of sepsis than CRP, interleukin-6 and lactate levels.
Our findings showed that PCT levels increase earlier in sepsis than CRP levels, which might contribute to an earlier diagnosis. An increase in PCT levels parallel to the severity of the inflammatory response to infection has been reported by various authors 6, 7, 9, 10, 13, 14 . Table 5 summarizes the findings of some procalcitonin studies. The trend of increasing levels of PCT with increasing severity of the septic state is confirmed in almost all studies, however the magnitude of PCT elevation during severe sepsis and septic shock is rather inconsistent. This discrepancy suggests a different magnitude of inflammatory response in different patient groups. Different methods of data presentation using mean or median values of admission, maximum or pooled PCT, also prevents achieving uniform results for each stage of sepsis. Moreover, in postoperative patients, surgical trauma itself may be associated with higher PCT levels 15, 16 .
In this study, PCT concentrations demonstrated increases parallel to rising SOFA and APACHE II score levels. In contrast, CRP concentrations were found elevated also at low SOFA and APACHE II scores. Increasing PCT concentrations during higher categories of sepsis-related severity scores were previously reported by Zeni et al 17 and Meisner et al 18 . In a recent study, Claeys et al 19 showed that PCT levels at admission correlated with APACHE II scores in patients with acute septic shock. Because a similar correlation could not be demonstrated between CRP and APACHE II scores, the authors suggest that PCT reflects the clinical severity of sepsis better than CRP.
The comparison of infected patients with the noninfected SIRS population yielded significant differences in PCT levels, APACHE II and SOFA scores. In contrast to those parameters, comparable CRP values were found in infected and non-infected patients. This finding highlights the dubious value of CRP in distinguishing SIRS from infection.
An important finding of this study was the increase in PCT levels in non-survivors. Moderately increased PCT levels in some of the non-survivors increased dramatically on the last measurement obtained before death. A possible explanation of this sharp increase in PCT levels was the augmentation of the infectious inflammatory response due to secondary bacteraemia, which was frequently observed in severe sepsis and septic shock patients. Secondary bacteraemia was often due to nosocomial infection in which the causative organisms were resistant to antibiotic therapy leading to death in most cases. The trend of PCT levels in the non-survivor group of our patient population was strikingly different from that of survivors in whom PCT levels decreased with the resolu-tion of the disease state. Similar to our findings, Oberhoffer et al 20 reported that PCT levels increased during the course of sepsis in non-survivors whereas levels decreased in surviving patients.
However, the question of whether high PCT is a cause or a result of the intense inflammatory reaction should also be considered. It has been suggested that PCT might actually mediate bacterial sepsis and the inflammatory response 21 . Nylen et al 22 investigated this hypothesis in an experimental model of sepsis and reported that PCT exacerbated mortality after a septic insult, whereas its antiserum attenuated this effect. It may be that PCT will serve as a target for either neutralization or elimination in future trials 23 .
In summary, our results demonstrate that PCT serves not only as a marker of severe infection in the inflammatory response, but also as a parameter that can be used to monitor the course of the septic state. Other than identifying the development of infection and the severity of the inflammatory response, its ability to guide treatment needs to be further evaluated. 
